TJHA
AZN icon

Thomas J. Herzfeld Advisors’s AstraZeneca AZN Stock Holding History

Thomas J. Herzfeld Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18
Closed -$2.73K – 170
2024
Q2 		$2.73K Buy
+18
New +$2.71K ﹤0.01% 182
2023
Q4 		– Sell
-83
Closed -$11.2K – 174
2023
Q3 		$11.2K Hold
83
– – ﹤0.01% 174
2023
Q2 		$11.9K Sell
83
-13
-14% -$1.91K ﹤0.01% 170
2023
Q1 		$13.3K Hold
96
– – 0.01% 143
2022
Q4 		$13K Buy
96
+28
+41% +$3.51K 0.01% 147
2022
Q3 		$7K Hold
68
– – ﹤0.01% 172
2022
Q2 		$9K Hold
68
– – ﹤0.01% 168
2022
Q1 		$9K Hold
68
– – ﹤0.01% 184
2021
Q4 		$8K Hold
68
– – ﹤0.01% 223
2021
Q3 		$8K Hold
68
– – ﹤0.01% 211
2021
Q2 		$8K Buy
68
+18
+36% +$1.98K ﹤0.01% 222
2021
Q1 		$5K Hold
50
– – ﹤0.01% 247
2020
Q4 		$5K Buy
50
+11
+28% +$1.17K ﹤0.01% 234
2020
Q3 		$4K Hold
39
– – ﹤0.01% 198
2020
Q2 		$4K Buy
+39
New +$4.03K ﹤0.01% 229
2017
Q3 		– Sell
-176
Closed -$12K – 290
2017
Q2 		$12K Sell
176
-117
-40% -$7.64K 0.01% 231
2017
Q1 		$18K Sell
293
-96
-25% -$5.59K 0.01% 273
2016
Q4 		$21K Buy
389
+44
+13% +$2.5K 0.01% 276
2016
Q3 		$23K Sell
345
-590
-63% -$38.6K 0.01% 255
2016
Q2 		$56K Buy
935
+55
+6% +$3.19K 0.03% 187
2016
Q1 		$50K Sell
880
-107
-11% -$6.43K 0.03% 199
2015
Q4 		$67K Hold
987
– – 0.03% 189
2015
Q3 		$63K Buy
987
+100
+11% +$6.58K 0.03% 180
2015
Q2 		$28K Buy
+887
New +$60.7K 0.01% 222

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Thomas J. Herzfeld Advisors's AZN Position: Q3 2024 in Review

Thomas J. Herzfeld Advisors sold out of AstraZeneca (AZN) in Q3 2024, closing a stake of 18 shares — an estimated $2.73K sold.

Thomas J. Herzfeld Advisors first reported a position in AZN in Q2 2015 and held it in 24 quarters. The position peaked at $67K in Q4 2015. 1,230 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

  • Thomas J. Herzfeld Advisors reported no remaining AstraZeneca position as of Q3 2024 after selling out during the quarter.
  • Thomas J. Herzfeld Advisors sold 18 AstraZeneca shares in Q3 2024, an estimated $2.73K.
  • Thomas J. Herzfeld Advisors first reported a position in AstraZeneca in Q2 2015 and held it in 24 quarters.
  • Thomas J. Herzfeld Advisors's AstraZeneca position peaked at $67K in Q4 2015.
  • 1,230 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on Thomas J. Herzfeld Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.